Nova BioGenetics, Inc. engages in the discovery, development, and commercialization of antibiotic and antimicrobial agents for use in the industrial and pharmaceutical sectors primarily in the United States. The company operates in two divisions, Specialty Chemicals and Bio-pharmaceuticals. The Specialty Chemicals division provides antimicrobial products, which incorporate molecularly-bonded antimicrobial agents in various applications, including industrial, medical, commercial and healthcare use, synthetic, woven and nonwoven textile products, fibers, fabrics, liquids, cleaning products for general households, sealants, adhesives, stains, caulking compounds, coating systems, and other surface materials. The companys technology is used to protect from various micro-organisms, including certain viruses, mold, mildew, fungi, yeasts, and gram bacteria. The Bio-pharmaceuticals division engages in the development and commercialization of new antibiotics, antivirals, and derivatives. Its customers include multinationals/global companies, wholesalers, and smaller national companies. Nova BioGenetics was incorporated in 2001 and is headquartered in Atlanta, Georgia.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for NVBG